# Expression of Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PDL-1) in Acute Lymphoblastic Leukemia in Pediatric

> **NCT05428111** · NA · UNKNOWN · sponsor: **Sohag University** · enrollment: 50 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia in Pediatric

## Interventions

- **DIAGNOSTIC_TEST:** flow cytometric immunophynotyping

## Key facts

- **NCT ID:** NCT05428111
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08
- **Primary completion:** 2023-08
- **Final completion:** 2023-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05428111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05428111, "Expression of Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PDL-1) in Acute Lymphoblastic Leukemia in Pediatric". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05428111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*